This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Novartis Ag, Novartis Pharma Ag. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Olja Kodrasi: Innovator in Chimeric Antigen Receptors
Introduction
Olja Kodrasi is a notable inventor based in Quincy, MA (US). He has made significant contributions to the field of immunotherapy through his innovative work on chimeric antigen receptors (CARs). His research focuses on enhancing immune effector cells, such as T cells and NK cells, to improve their effectiveness in targeting cancer cells.
Latest Patents
Olja Kodrasi holds one patent titled "Chimeric antigen receptors and uses thereof." This invention provides immune effector cells that express a chimeric antigen receptor, along with the compositions and methods associated with this technology. The potential applications of this invention are vast, particularly in the realm of cancer treatment.
Career Highlights
Kodrasi is currently employed at Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to collaborate with other experts in the field and contribute to groundbreaking advancements in immunotherapy.
Collaborations
Some of his notable coworkers include Aida Abujoub and John Blankenship. Their collaborative efforts have furthered the research and development of innovative therapies in the field of immunology.
Conclusion
Olja Kodrasi's contributions to the development of chimeric antigen receptors represent a significant advancement in cancer treatment. His work continues to inspire innovation in the field of immunotherapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile